Lexeo Therapeutics, Inc. Common Stock
USD4.71
-0.10 (-1.98%)
CEO
R. Nolan Townsend
IPO Date
2023-11-03
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$4.79
Prev. Close
$4.81
Day Low
$4.67
Day High
$4.88
52W Low
$3.60
52W High
$10.99
Market Cap
$0.37B
Volume
0.46M
| -2.1 |
| 31 Dec 2023 | FY | 0.0% | 0.0% | -58.5% | -47.5% | 0.10 | 7.21 | -5.4 |
| 31 Dec 2022 | FY | 100.0% | -9063.8% | 52.5% | -61.1% | -0.12 | 5.58 | -4.3 |
| 31 Dec 2021 | FY | 100.0% | -3055.0% | 91.0% | -37.0% | 0.00 | 18.35 | -5.0 |
| 31 Dec 2020 | FY | 100.0% | -993.8% | 93.1% | -17.5% | 0.00 | 42.15 | -49.1 |
| -9.1 |
| 30 Sept 2025 | Q3 | 0.0% | 0.0% | -16.8% | -14.1% | 0.07 | 7.40 | -5.0 |
| 30 Jun 2025 | Q2 | 0.0% | 0.0% | -18.9% | -14.8% | 0.06 | 4.43 | -1.7 |
| 31 Mar 2025 | Q1 | 0.0% | 0.0% | -37.1% | -26.0% | 0.11 | 3.42 | -0.9 |
| 31 Dec 2024 | Q4 | 0.0% | 0.0% | -22.2% | -17.6% | 0.08 | 5.52 | -2.1 |
| 30 Sept 2024 | Q3 | 0.0% | 0.0% | -21.2% | -17.0% | 0.07 | 5.95 | -2.5 |
| 30 Jun 2024 | Q2 | 0.0% | 0.0% | -12.9% | -11.1% | 0.07 | 9.38 | -6.1 |
| 31 Mar 2024 | Q1 | 0.0% | 0.0% | -11.9% | -10.2% | 0.06 | 9.16 | -5.1 |
| 31 Dec 2023 | Q4 | 0.0% | 0.0% | -12.5% | -10.1% | 0.10 | 7.21 | -6.5 |